Related Experiment Video
Updated: Jun 13, 2026

Manual Muscle Testing: A Method of Measuring Extremity Muscle Strength Applied to Critically Ill Patients
Published on: April 12, 2011
Critical illness polyneuropathy and myopathy in pediatric intensive care: A review
Stephen Williams1, Iain A Horrocks, Robert A Ouvrier
1Helen McMillan Paediatric Intensive Care Unit, The Children's Hospital at Westmead, NSW, Australia.
Insights
Critical illness polyneuropathy and myopathy (CIPNM) are recognized in adults and may affect critically ill children, causing weakness. Further pediatric studies are needed to understand their prevalence and impact.
Area of Science:
- Neurology
- Intensive Care Medicine
- Pediatrics
Background:
- Critical illness polyneuropathy and myopathy (CIPNM) are common in critically ill adults, leading to weakness and prolonged mechanical ventilation.
- These conditions are less frequently reported in children, with limited understanding of their prevalence and clinical significance.
Purpose of the Study:
- To review the existing medical literature on critical illness polyneuropathy and myopathy in the pediatric population.
- To summarize current knowledge and identify research gaps regarding CIPNM in critically ill children.
Main Methods:
- Systematic literature search of Medline and EMBASE databases using relevant keywords for pediatric and adult critical illness neuropathy and myopathy.
- Inclusion of all studies on pediatric CIPNM and review of adult literature for comparative understanding.
Main Results:
- CIPNM is well-documented in adults, affecting 32-100% of those ventilated for over 3 days.
- Pediatric cases of CIPNM are infrequently reported, with considerable overlap in clinical and neurophysiologic features between pediatric and adult patients.
Conclusions:
- CIPNM can contribute to significant morbidity in critically ill children.
- While clinically and electrophysiologically similar to adults, prospective studies are essential to define the frequency, natural history, and clinical importance of CIPNM in pediatric intensive care.
Objective:
To review the medical literature on critical illness polyneuropathy and myopathy in childhood.
Data Source:
Medline and EMBASE were searched using the following terms: critical illness (neuropathy, polyneuropathy, and myopathy), critical care (neuropathy, polyneuropathy, and myopathy), acute myopathy, acute necrotizing myopathy, children, and pediatric. The references listed in publications thus identified were also reviewed.
Study Selection And Data Extraction:
All studies relating to pediatric critical illness polyneuropathy and myopathy were included. The adult literature was also reviewed as to the current understanding of critical illness polyneuropathy and myopathy.
Data Synthesis:
Critical illness polyneuropathy and critical illness myopathy are well recognized in adults, in whom they commonly cause generalized weakness and muscle wasting, with failure to wean from mechanical ventilation. Critical illness polyneuropathy and critical illness myopathy are reported in 32-100% of critically ill adult patients ventilated for >3 days. There is significant clinical and neurophysiologic overlap between the two conditions, such that the term critical illness polyneuropathy and myopathy (CIPNM) is often used. Critical illness polyneuropathy and critical illness myopathy have only occasionally been reported in childhood, and little is known of their prevalence or clinical significance in this population. This article summarizes the pediatric literature on critical illness polyneuropathy and critical illness myopathy and highlights areas for future research in critically ill children.
Conclusions:
Critical illness polyneuropathy and myopathy may cause significant morbidity in critically ill children. These conditions seem to be clinically and electrophysiologically similar in children and adults, but prospective studies of these entities are required to better characterize their frequency, natural history, and clinical significance in pediatric practice.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury V: Interprofessional Care

